SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-022108
Filing Date
2019-04-30
Accepted
2019-04-30 07:27:45
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv520014_defa14a.htm DEFA14A 18277
2 GRAPHIC image_001.jpg GRAPHIC 95220
3 GRAPHIC image_002.jpg GRAPHIC 162008
4 GRAPHIC image_003.jpg GRAPHIC 52302
5 GRAPHIC image_004.jpg GRAPHIC 4673
  Complete submission text file 0001144204-19-022108.txt   450042
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35366 | Film No.: 19778438
SIC: 2834 Pharmaceutical Preparations